Abstract
Fluoroquinolone is one of the first-line antibiotics recommended for treating community-acquired pneumonia. However, using fluroquinolones for presumptive community-acquired pneumonia can delay the diagnosis and the treatment of pulmonary tuberculosis because of its strong activity against mycobacteria. Here, we report a case of a 54-year-old female taking immunosuppressants after a renal transplant whose diagnosis of pulmonary tuberculosis was delayed as a result of the use of levofloxacin and amikacin under the original impression of community-acquired pneumonia. This case suggests that clinicians should consider the possibility of pulmonary tuberculosis in the case of a partial response of the pneumonia to flouroquinolones and/or aminoglycosides.
| Original language | English |
|---|---|
| Pages (from-to) | 395-401 |
| Number of pages | 7 |
| Journal | Tuberculosis and Respiratory Diseases |
| Volume | 55 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 2003 Oct |
Fingerprint
All Science Journal Classification (ASJC) codes
- Pulmonary and Respiratory Medicine
- Infectious Diseases
Cite this
}
A Case of Pulmonary Tuberculosis with Delayed Diagnosis Due to the Temporary Clinical Improvement after Use of Levofloxacin and Amikacin under the Impression of Community Acquired Pneumonia. / Lee, Hee Seok; Kang, Young Ae; Oh, Jin Young; Lee, Jae Ho; Yoo, Chul Gyu; Lee, Choon Taek; Kim, Young Whan; Han, Sung Koo; Shim, Young Soo; Yim, Jae Joon.
In: Tuberculosis and Respiratory Diseases, Vol. 55, No. 4, 10.2003, p. 395-401.Research output: Contribution to journal › Article
TY - JOUR
T1 - A Case of Pulmonary Tuberculosis with Delayed Diagnosis Due to the Temporary Clinical Improvement after Use of Levofloxacin and Amikacin under the Impression of Community Acquired Pneumonia
AU - Lee, Hee Seok
AU - Kang, Young Ae
AU - Oh, Jin Young
AU - Lee, Jae Ho
AU - Yoo, Chul Gyu
AU - Lee, Choon Taek
AU - Kim, Young Whan
AU - Han, Sung Koo
AU - Shim, Young Soo
AU - Yim, Jae Joon
PY - 2003/10
Y1 - 2003/10
N2 - Fluoroquinolone is one of the first-line antibiotics recommended for treating community-acquired pneumonia. However, using fluroquinolones for presumptive community-acquired pneumonia can delay the diagnosis and the treatment of pulmonary tuberculosis because of its strong activity against mycobacteria. Here, we report a case of a 54-year-old female taking immunosuppressants after a renal transplant whose diagnosis of pulmonary tuberculosis was delayed as a result of the use of levofloxacin and amikacin under the original impression of community-acquired pneumonia. This case suggests that clinicians should consider the possibility of pulmonary tuberculosis in the case of a partial response of the pneumonia to flouroquinolones and/or aminoglycosides.
AB - Fluoroquinolone is one of the first-line antibiotics recommended for treating community-acquired pneumonia. However, using fluroquinolones for presumptive community-acquired pneumonia can delay the diagnosis and the treatment of pulmonary tuberculosis because of its strong activity against mycobacteria. Here, we report a case of a 54-year-old female taking immunosuppressants after a renal transplant whose diagnosis of pulmonary tuberculosis was delayed as a result of the use of levofloxacin and amikacin under the original impression of community-acquired pneumonia. This case suggests that clinicians should consider the possibility of pulmonary tuberculosis in the case of a partial response of the pneumonia to flouroquinolones and/or aminoglycosides.
UR - http://www.scopus.com/inward/record.url?scp=0347753923&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0347753923&partnerID=8YFLogxK
U2 - 10.4046/trd.2003.55.4.395
DO - 10.4046/trd.2003.55.4.395
M3 - Article
AN - SCOPUS:0347753923
VL - 55
SP - 395
EP - 401
JO - Tuberculosis and Respiratory Diseases
JF - Tuberculosis and Respiratory Diseases
SN - 1738-3536
IS - 4
ER -